Cargando…

Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19

BACKGROUND: Acute kidney injury (AKI) is a severe complication of coronavirus disease-2019 (COVID-19). This study aims to evaluate incidence, risk factors and case-fatality rate of AKI in patients with COVID-19. METHODS: We reviewed the health medical records of 307 consecutive patients with COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alfano, Gaetano, Ferrari, Annachiara, Fontana, Francesco, Mori, Giacomo, Magistroni, Riccardo, Meschiari, Marianna, Franceschini, Erica, Menozzi, Marianna, Cuomo, Gianluca, Orlando, Gabriella, Santoro, Antonella, Digaetano, Margherita, Puzzolante, Cinzia, Carli, Federica, Bedini, Andrea, Milic, Jovana, Coloretti, Irene, Raggi, Paolo, Mussini, Cristina, Girardis, Massimo, Cappelli, Gianni, Guaraldi, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245663/ https://www.ncbi.nlm.nih.gov/pubmed/34196877 http://dx.doi.org/10.1007/s10157-021-02092-x

Ejemplares similares

Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients
por: Alfano, Gaetano, et al.
Publicado: (2021)

Acid base disorders in patients with COVID-19
por: Alfano, Gaetano, et al.
Publicado: (2021)

The Impact of COVID-19 on UNAIDS 90–90–90 Targets: Calls for New HIV Care Models
por: Guaraldi, Giovanni, et al.
Publicado: (2021)

Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period
por: Franceschini, E., et al.
Publicado: (2020)

Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study
por: Franceschini, Erica, et al.
Publicado: (2021)

Hypokalemia in Patients with COVID-19
por: Alfano, Gaetano, et al.
Publicado: (2021)

Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature
por: Bacca, Erica, et al.
Publicado: (2021)

First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
por: Meschiari, Marianna, et al.
Publicado: (2022)

Peritoneal dialysis in the time of coronavirus disease 2019
por: Alfano, Gaetano, et al.
Publicado: (2020)

Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator
por: Mussini, Cristina, et al.
Publicado: (2021)

The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study
por: Milic, Jovana, et al.
Publicado: (2021)

Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria
por: Santoro, Antonella, et al.
Publicado: (2020)

Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study
por: Meschiari, Marianna, et al.
Publicado: (2021)

Acute myocarditis as the main clinical manifestation of SARS-CoV 2 infection
por: Cuomo, Gianluca, et al.
Publicado: (2020)

Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach
por: Puzzolante, Cinzia, et al.
Publicado: (2019)

Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015–2021)
por: Meschiari, Marianna, et al.
Publicado: (2022)

Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections
por: Gallerani, Altea, et al.
Publicado: (2023)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia—Challenges, strengths, and opportunities in a global health emergency
por: Ferrari, Davide, et al.
Publicado: (2020)

1979. Five-Year Impact of an Antimicrobial Stewardship Program on Nosocomial Candidemia: An Interrupted Time-Series Analysis Study
por: Bedini, Andrea, et al.
Publicado: (2019)

Tocilizumab in patients with severe COVID-19: a retrospective cohort study
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature
por: Burastero, Giulia Jole, et al.
Publicado: (2022)

The dynamic association between Frailty, CD4 and CD4/CD8 ratio in people aging with HIV
por: Guaraldi, Giovanni, et al.
Publicado: (2019)

Which criteria should we use to end isolation in hemodialysis patients with COVID-19?
por: Alfano, Gaetano, et al.
Publicado: (2022)

The frail world of haemodialysis patients in the COVID-19 pandemic era: a systematic scoping review
por: Alfano, Gaetano, et al.
Publicado: (2021)

Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals?
por: Medioli, Filippo, et al.
Publicado: (2022)

Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART
por: Franconi, Iacopo, et al.
Publicado: (2019)

CD4/CD8 ratio is not predictive of multi-morbidity prevalence in HIV-infected patients but identify patients with higher CVD risk
por: Menozzi, Marianna, et al.
Publicado: (2014)

Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study
por: Franceschini, Erica, et al.
Publicado: (2017)

Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study
por: Coloretti, Irene, et al.
Publicado: (2021)

One‐year persistence of neutralizing anti‐SARS‐CoV‐2 antibodies in dialysis patients recovered from COVID‐19
por: Alfano, Gaetano, et al.
Publicado: (2021)

Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience
por: Alfano, Gaetano, et al.
Publicado: (2022)

Critical COVID-19 patients through first, second, and third wave: retrospective observational study comparing outcomes in intensive care unit
por: Coloretti, Irene, et al.
Publicado: (2023)

Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
por: Gatto, Ilenia, et al.
Publicado: (2022)

Association between Pulmonary Aspergillosis and Cytomegalovirus Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study
por: Caciagli, Valeria, et al.
Publicado: (2023)

Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature
por: Meschiari, Marianna, et al.
Publicado: (2020)

Seroconversion after COVID-19 vaccine in a dialysis patient on immunosuppressants
por: Alfano, Gaetano, et al.
Publicado: (2021)

Re: ‘Methodological evaluation of bias in observational COVID-19 studies on drug effectiveness’ by Wolkewitz et al.
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2021)

Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection
por: Mussini, Cristina, et al.
Publicado: (2021)

The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients
por: Campani, Simone, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ou2epeoro41fu6v2lru98jhm3a